Timing of Oral P2Y12 Inhibitor Administration in Non-ST Elevation Acute Coronary Syndrome.
Timing of Oral P2Y12 Inhibitor Administration in Non-ST Elevation Acute Coronary Syndrome.
G. Tarantini,M. Mojoli,40 Authors,G. Musumeci
2020 · DOI: 10.1016/j.jacc.2020.08.053
Journal of the American College of Cardiology · 70 Citations
TLDR
Downstream and upstream oral P2Y12 inhibitors administration strategies were associated with low incidence of ischemic and bleeding events and minimal numerical difference of event rates between treatment groups, suggesting the unlikelihood of enhanced efficacy of one strategy over the other.